Prenetics Global Limited Class A Ordinary SharePRE
Recorded

Prenetics Global Limited Class A Ordinary Share 2026 Q2 Earnings Call

Review the key takeaways and the transcript of this earnings call.

PeriodQ2 2026Duration1 hr 31 minParticipants10

Transcript

Preview the first fifteen paragraphs, organized by speaker.

Danny YeungCo-Founder and CEO

Thank you, Shannon. Good morning, everyone. Before anything else, thank you so much for being here. This is actually the first live earnings video webcast we have done in our company's history. From the numbers that are joining right now, it may be the largest group of our shareholders ever gathered in one place. So whether you manage a fund, hold a single share, or are simply here because you drink the sachet every morning, welcome. This is for you. Here is why we are doing it this way. Our shareholders range from global institutions to people who found IM8 as customers and became shareholders. We believe every one of them deserves the same depth of information at the same moment. This moment, we have opened the book to everyone at once. We can do that for a simple reason.

Danny YeungCo-Founder and CEO

We now have 20 months of data, every cohort, every month, every market measured end to end. Enough history that numbers no longer need my adjectives. I will say this plainly, I do not know of another company, publicly traded or private, that has shown its business in this level of detail in which we are showing you today. I just released a 40-page shareholder letter written to be read, not skimmed. An additional 80-page investor deck that shows you this business the way I see it internally. Every single cohort, every vintage, our full acquisition cost month by month, and even independent cart data measuring our retention against every single brand in our category. In this stream, you hear from us directly. Feel free to ask us anything at the end of this call. A business compounding this fast deserves to be examined, not summarized.

Danny YeungCo-Founder and CEO

When the numbers are this good, transparency is a weapon. The day that numbers softened, someday you will read it from us first in that letter. One promise I want to make in the next half hour is I am not going to be standing here and just reading you that letter. However, hopefully everyone here listening in can read it later today. What I owe you is a part of the document that cannot do the story of what actually happened, how a brand that did not exist two Decembers ago crossed last month a line most consumer companies never reach. But before I talk a single number, I want to show everyone what we are building first. We made this video, two minutes.

Speaker

Please enjoy. Prenetics is the parent company of IM8.

Speaker

Talk to us a little bit about what IM8 is.

Speaker

We created this supplement. Create nutrition simple.

Speaker

IM8 just covers everything in one sachet.

Speaker

What are you willing to do to be the best?

Speaker

We're very strategic in the businesses that we go into. I don't know whether any of you know about IM8, but you should get IM8 because it's got 92 ingredients.

Speaker

Is that your secret, IM8?

Speaker

That's my secret, IM8. You don't have to take 15 or 18 tablets every single morning.

Speaker

It's just easy, and it's so good for you and the longevity of your life.

Speaker

I look forward to this every single morning. It's actually my incentive to drink more fluids because I just don't really enjoy it unless I mix that IM8 in it.

Speaker

Since the moment that I took IM8, man, I've been feeling incredible.

Speaker

IM8 gives me that immunity and strength that I can wake up every morning and feel good and perform well.

FULL TRANSCRIPT

Continue the full translated transcript in StockNow.

Log in to unlock every statement, the English original, and speaker-by-speaker history.

Log in for the full transcript

More recent earnings calls

View earnings calendar